4//SEC Filing
Elvig Mark F 4
Accession 0001209191-21-001057
CIK 0001000229other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:22 PM ET
Size
11.0 KB
Accession
0001209191-21-001057
Insider Transaction Report
Form 4
Elvig Mark F
VP, Counsel & Secretary
Transactions
- Exercise/Conversion
Common Shares
2020-12-31+2,600→ 13,635 total - Other
Common Shares
2020-12-31−739→ 12,896 total - Exercise/Conversion
Performance Shares
2020-12-31−2,600→ 0 totalExercise: $0.00→ Common Shares (2,600 underlying) - Tax Payment
Common Shares
2020-12-31$26.51/sh−454$12,036→ 12,442 total
Holdings
- 1,245(indirect: By 401(k))
Common Shares
Footnotes (2)
- [F1]Mr. Elvig transferred 739 shares to his former spouse pursuant to a divorce settlement.
- [F2]These awards vested at the end of a three-year performance period that began on January 1, 2018 and ended December 31, 2020 (the "Performance Period"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001435153
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:22 PM ET
- Size
- 11.0 KB